Skip to content

Chemed CHE Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin32.5%-2.6pp35.1%-0.1pp35.3%-0.6pp35.8%-0.1pp
Operating margin13.4%-1.7pp15.1%0.0pp15%-1.0pp16.1%+0.1pp
Net margin10.5%-1.9pp12.4%+0.4pp12%+0.3pp11.7%-0.9pp
EBITDA margin15.9%-1.7pp17.7%-0.1pp17.7%-1.1pp18.9%+0.1pp
Free cash flow margin12.9%-2.3pp15.1%+3.1pp12.1%+0.2pp11.8%+0.1pp
Returns
Return on equity25.3%-1.8pp27.1%-1.5pp28.6%-6.5pp35.1%-0.1pp
Return on assets16.5%-1.6pp18.1%+0.6pp17.5%-0.4pp17.9%-1.4pp
Return on invested capital27%-3.4pp30.4%+0.2pp30.2%-1.2pp31.4%-1.8pp
Efficiency
Asset turnover1.6×+0.1×1.5×0.0×1.5×-0.1×1.5×0.0×
Inventory turnover216.9×+60.8×156.2×+24.6×131.6×-2.8×134.4×-24.8×
Liquidity
Current ratio1.1×-0.3×1.4×-0.2×1.6×+0.7×0.9×+0.2×
Quick ratio-0.3×1.4×-0.2×1.6×+0.7×0.9×+0.2×
Cash ratio0.3×-0.4×0.6×-0.2×0.8×+0.6×0.2×+0.1×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×-0.2×0.3×-0.2×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×-0.1×0.2×-0.1×
Net debt / EBITDA0.2×+0.3×-0.1×+0.2×-0.3×-0.7×0.4×-0.3×
Interest coverage193.3×-12.6×205.9×+96.3×109.6×+34.6×74.9×-109×
Per Share
Book value per share$67.73-8.1%$73.69+1.1%$72.89+37.8%$52.90+35.3%
Valuation
Market capitalization$6.04B-24.0%$7.94B-10.1%$8.83B+16.0%$7.61B-4.0%
Enterprise value$6.11B-22.7%$7.9B-9.2%$8.7B+11.8%$7.78B-5.3%
Price / earnings22.8×-3.5×26.3×-6.1×32.4×+1.9×30.5×+1.0×
Price / sales2.4×-0.9×3.3×-0.6×3.9×+0.3×3.6×-0.1×
Price / book6.2×-0.9×7.1×-0.9×-1.6×9.5×-3.2×
EV / EBITDA15.1×-3.2×18.4×-3.3×21.7×+2.4×19.3×-1.1×
EV / sales2.4×-0.8×3.2×-0.6×3.8×+0.2×3.6×-0.2×
Free cash flow yield5.4%+0.8pp4.6%+1.5pp3.1%-0.2pp3.3%+0.2pp
Earnings yield4.4%+0.6pp3.8%+0.7pp3.1%-0.2pp3.3%-0.1pp
Dividend yield0.5%+0.2pp0.3%+0.1pp0.3%0.0pp0.3%0.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Chemed's profit margins?
Chemed (CHE) runs a 32.4% gross margin and a 12.9% operating margin, with a 10.2% net margin.
Where do Chemed's ratios come from?
Every ratio is computed from Chemed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.